Effect of GLP-1 Agonist Therapy on Insulin Secretion in Adults With Pancreatic Insufficient Cystic Fibrosis and Abnormal Glucose Tolerance: a Randomized, Open-label, Cross-over Trial
Latest Information Update: 04 Mar 2024
At a glance
- Drugs Dulaglutide (Primary)
- Indications Exocrine pancreatic insufficiency
- Focus Therapeutic Use
- 21 Apr 2021 Status changed from not yet recruiting to recruiting.
- 02 Feb 2021 New trial record